Pseudoporphyria induced by oral contraceptive pills [5]

Archives of Dermatology

Volumn 139, Issue 2, 2003, Pages 227-228

  Silver, Eli A ^a   Silver, Adam H ^a   Silver, Diane S ^a   McCalmont, Timothy H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; LEVONORGESTREL; SUNSCREEN;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LABORATORY TEST; LETTER; PHYSICAL EXAMINATION; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PSEUDOPORPHYRIA; SKIN BIOPSY; SUN EXPOSURE;

ADULT; BIOPSY, NEEDLE; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; PHOTOSENSITIVITY DISORDERS; PORPHYRIAS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 0037322172     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.2.227     Document Type: Letter

References (5)

1. Mor Z, Caspi E. Cutaneous complications of hormonal replacement therapy. Clin Dermatol. 1997;15:147-154.
2. Epstein JH. Pseudoporphyria and UVA suntan salons [abstract]. Photochem Photobiol. 1987;45(suppl):40S.
3. Green JJ, Manders SM. Pseudoporphyria. J Am Acad Dermalot. 2001;44:100-108.
4. Cooper SM, George S. Photosensitivity reaction associated with use of the combined oral contraceptive. Br J Dermatol. 2001;144:641-642.
5. Schanbacher CD, Vanness ER, Daoud MS, et al. Pseudoporphyria: a clinical and biochemical study of 20 patients. Mayo Clin Proc. 2001;76:488-492.